178 related articles for article (PubMed ID: 24552217)
1. Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism.
Kem DC; Li H; Velarde-Miranda C; Liles C; Vanderlinde-Wood M; Galloway A; Khan M; Zillner C; Benbrook A; Rao V; Gomez-Sanchez CE; Cunningham MW; Yu X
J Clin Endocrinol Metab; 2014 May; 99(5):1790-7. PubMed ID: 24552217
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of angiotensin II type 1 receptor (AT1R)-activating autoantibodies in primary aldosteronism.
Li H; Yu X; Cicala MV; Mantero F; Benbrook A; Veitla V; Cunningham MW; Kem DC
J Am Soc Hypertens; 2015 Jan; 9(1):15-20. PubMed ID: 25537460
[TBL] [Abstract][Full Text] [Related]
3. Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism.
Williams TA; Jaquin D; Burrello J; Philippe A; Yang Y; Rank P; Nirschl N; Sturm L; Hübener C; Dragun D; Bidlingmaier M; Beuschlein F; Reincke M
Hypertension; 2019 Oct; 74(4):784-792. PubMed ID: 31476909
[TBL] [Abstract][Full Text] [Related]
4. AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction.
Liles C; Li H; Veitla V; Liles JT; Murphy TA; Cunningham MW; Yu X; Kem DC
Hypertension; 2015 Oct; 66(4):830-5. PubMed ID: 26259590
[TBL] [Abstract][Full Text] [Related]
5. Novel retro-inverso peptide inhibitor reverses angiotensin receptor autoantibody-induced hypertension in the rabbit.
Li H; Kem DC; Zhang L; Huang B; Liles C; Benbrook A; Gali H; Veitla V; Scherlag BJ; Cunningham MW; Yu X
Hypertension; 2015 Apr; 65(4):793-9. PubMed ID: 25691619
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism.
Meyer LS; Gong S; Reincke M; Williams TA
Horm Metab Res; 2020 Jun; 52(6):379-385. PubMed ID: 32168525
[TBL] [Abstract][Full Text] [Related]
7. AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism?
Piazza M; Seccia TM; Caroccia B; Rossitto G; Scarpa R; Persichitti P; Basso D; Rossi GP
Hypertension; 2019 Oct; 74(4):793-799. PubMed ID: 31476908
[TBL] [Abstract][Full Text] [Related]
8. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
Rossitto G; Regolisti G; Rossi E; Negro A; Nicoli D; Casali B; Toniato A; Caroccia B; Seccia TM; Walther T; Rossi GP
Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome.
Yu X; Li H; Murphy TA; Nuss Z; Liles J; Liles C; Aston CE; Raj SR; Fedorowski A; Kem DC
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29618472
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role.
Sabbadin C; Ceccato F; Ragazzi E; Boscaro M; Betterle C; Armanini D
J Clin Hypertens (Greenwich); 2018 Sep; 20(9):1313-1318. PubMed ID: 30058103
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of angiotensin II type 1 receptor subtypes within the cerebral microvasculature.
Yamasaki E; Thakore P; Krishnan V; Earley S
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H461-H469. PubMed ID: 31886721
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
14. Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles.
Hong K; Zhao G; Hong Z; Sun Z; Yang Y; Clifford PS; Davis MJ; Meininger GA; Hill MA
J Physiol; 2016 Dec; 594(23):7027-7047. PubMed ID: 27531064
[TBL] [Abstract][Full Text] [Related]
15. The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.
Wu Y; Nakagawa S; Takahashi H; Kawabata Y; Suzuki E; Uehara Y
Hypertens Res; 2016 May; 39(5):295-301. PubMed ID: 26763849
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin type 1 receptor autoantibody from preeclamptic patients induces human fetoplacental vasoconstriction.
Zhang S; Zheng R; Yang L; Zhang X; Zuo L; Yang X; Bai K; Song L; Tian J; Yang J; Liu H
J Cell Physiol; 2013 Jan; 228(1):142-8. PubMed ID: 22566240
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody against angiotensin II type I receptor induces pancreatic β-cell apoptosis via enhancing autophagy.
Wang J; Li D; Zhang Z; Zhang Y; Lei Z; Jin W; Cao J; Jiao X
Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):784-795. PubMed ID: 33928341
[TBL] [Abstract][Full Text] [Related]
18. AT1R autoantibody promotes phenotypic transition of smooth muscle cells by activating AT1R-OAS2.
Zhang X; Li B; Yan Y; Sun F; Zhang S; Wang M; Liu H
Biochem Pharmacol; 2024 Jan; 219():115977. PubMed ID: 38092283
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
20. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells.
Xia Y; Wen H; Bobst S; Day MC; Kellems RE
J Soc Gynecol Investig; 2003 Feb; 10(2):82-93. PubMed ID: 12593997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
